I-cell disease
From Wikipedia, the free encyclopedia
| I-cell disease Classification and external resources |
|
| ICD-10 | E77.0 |
|---|---|
| ICD-9 | 272.7 |
| OMIM | 252500 |
| DiseasesDB | 29175 |
| eMedicine | ped/1150 |
| MeSH | D009081 |
Inclusion-cell (I-cell) disease, also referred to as mucolipidosis II (ML II),[1] is so named because waste products, thought to include carbohydrates, lipids, and proteins, accumulate into masses known as inclusion bodies. When tissues are examined under a microscope, the detection of inclusion bodies often provides a diagnosis of the disease.
Contents |
[edit] Presentation
ML II is a particularly severe form of ML that resembles one of the mucopolysaccharidoses called Hurler syndrome. Some physical signs, such as abnormal skeletal development, coarse facial features, and restricted joint movement, may be present at birth. Children with ML II usually have enlargement of certain organs, such as the liver or spleen, and sometimes even the heart valves. Affected children often fail to grow and develop in the first months of life. Delays in the development of their motor skills are usually more pronounced than delays in their cognitive (mental processing) skills. Children with ML II eventually develop a clouding on the cornea of their eyes and, because of their lack of growth, develop short-trunk dwarfism (underdeveloped trunk). These young patients are often plagued by recurrent respiratory tract infections, including pneumonia, otitis media (middle ear infections), and bronchitis. Children with ML II generally die before their seventh year of life, often as a result of congestive heart failure or recurrent respiratory tract infections.
[edit] Pathophysiology
I-cell disease is caused by an absence of GlcNAc phosphotransferase, which tags hydrolases with mannose-6-phosphate in the Golgi. Without mannose-6-phosphate to target them to the lysosomes, the enzymes are transported from the Golgi to the extracellular space. Hydrolases secreted into the blood stream cause little problem as they are deactivated in the neutral pH of the blood.
It can be associated with GNPTA.[2]
[edit] See also
[edit] References
- ^ Plante M, Claveau S, Lepage P, et al (March 2008). "Mucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population". Clin. Genet. 73 (3): 236–44. doi:. PMID 18190596.
- ^ Tiede S, Storch S, Lübke T, et al (2005). "Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase". Nat. Med. 11 (10): 1109–12. doi:. PMID 16200072.
[edit] Sources
- mucolipidoses at NINDS - article derived from detail sheet available here
|
||||||||||||||
